This page contains affiliate links. We may earn a commission at no extra cost to you.

$15–$30 for a 60-day supply

Check Price on Amazon
Evidence: Preliminary for most neuropathy types. Strongest evidence in CIPN prevention, where multiple small trials show protective effects against cisplatin and taxane-induced neuropathy. Theoretical rationale is strong; larger controlled trials in neuropathy are limited.

N-acetyl cysteine (NAC) is a supplement form of the amino acid cysteine and a direct precursor to glutathione — the body’s most powerful endogenous antioxidant. In the context of peripheral neuropathy, NAC’s primary interest lies in its ability to replenish glutathione levels in peripheral nerve cells, protecting them from the oxidative stress that drives nerve fiber damage in diabetic, chemotherapy-induced, and other oxidative neuropathies. NAC also has direct mucolytic and anti-inflammatory properties. Clinical evidence for NAC specifically in neuropathy is more limited than for alpha lipoic acid, but the mechanism is sound and complementary, and NAC is particularly well-studied in chemotherapy-induced peripheral neuropathy (CIPN) prevention. NAC is generally well-tolerated at typical supplement doses, affordable, and a reasonable adjunct in neuropathy protocols that address oxidative stress.

How It Works

NAC provides cysteine — the rate-limiting amino acid in glutathione synthesis — directly to cells. Intracellular glutathione (GSH) is a tri-peptide antioxidant that neutralizes reactive oxygen species (ROS) and reactive nitrogen species (RNS) that damage protein, lipid, and DNA structures in peripheral nerve axons and Schwann cells. In conditions like diabetic neuropathy and CIPN, chronic oxidative stress depletes local glutathione reserves, leaving nerve cells vulnerable to cumulative oxidative damage.

Beyond glutathione precursor activity, NAC has direct radical-scavenging properties, anti-inflammatory effects (modulating NF-κB pathway activation), and the ability to modulate mitochondrial function — another relevant target in neuropathy given that peripheral nerve maintenance is highly energy-intensive. In CIPN specifically, platinum-based and taxane chemotherapy agents generate ROS directly in peripheral neurons; NAC supplementation during chemotherapy may buffer this oxidative load.

CIPN Prevention Evidence

The most compelling human evidence for NAC in neuropathy is in chemotherapy-induced peripheral neuropathy prevention. Multiple studies have examined NAC as a neuroprotective agent during neurotoxic chemotherapy regimens. A 2003 randomized trial found that NAC significantly reduced the severity of neuropathy in patients receiving cisplatin chemotherapy, with improvements in nerve conduction parameters compared to placebo at 9 months. A subsequent study found benefit specifically in motor fiber conduction velocity, suggesting partial preservation of nerve function during platinum-based treatment.

For taxane-based chemotherapy (paclitaxel, docetaxel), evidence is more mixed — some animal studies show strong protection, while human trials have produced less consistent results. The difference may relate to the specific mechanisms of taxane versus platinum neurotoxicity. For cancer patients undergoing neurotoxic chemotherapy who are interested in supplement-based neuroprotection, NAC is among the more evidence-supported options — discuss with your oncologist before starting, as timing relative to chemotherapy administration matters.

Glutathione vs. NAC Supplementation

Some patients ask about taking glutathione directly rather than NAC. Oral glutathione supplements exist but have poor bioavailability — glutathione is broken down in the gut to its component amino acids before absorption, meaning oral glutathione supplements largely fail to increase cellular glutathione levels directly. NAC, by contrast, is absorbed intact and provides the cysteine precursor that cells use to manufacture their own glutathione — a more effective strategy for increasing intracellular glutathione.

Alternatives to NAC for glutathione support include liposomal glutathione (improved absorption compared to standard oral glutathione), S-acetyl glutathione (a modified form with better cellular uptake), and IV glutathione (available at some integrative medicine clinics and highly bioavailable — used in some CIPN and neuropathy protocols). Each approach has different evidence and practical trade-offs; discuss with your physician or integrative medicine practitioner.

Pros

• Directly replenishes glutathione — the primary endogenous antioxidant for nerve fiber protection
• Positive evidence in CIPN prevention — relevant for cancer patients receiving neurotoxic chemotherapy
• Well-tolerated at standard doses with mild side effect profile
• Affordable relative to more complex interventions
• Complementary mechanism to ALA and B vitamins — fits naturally into multi-supplement neuropathy protocols
• Long safety record as a pharmaceutical agent (IV NAC used for acetaminophen overdose)

Cons

• Human neuropathy trial evidence outside of CIPN is limited
• At high doses, NAC can cause GI side effects (nausea, diarrhea) and has a strong sulfurous odor
• May reduce efficacy of some chemotherapy agents if taken immediately before or after treatment — timing matters
• Cannot be taken with nitroglycerin — potentiates hypotension

Frequently Asked Questions

Can NAC be taken with alpha lipoic acid for neuropathy?

Yes — NAC and ALA have complementary mechanisms (NAC raises glutathione; ALA directly scavenges radicals and also raises glutathione) and are commonly combined in integrative neuropathy protocols. There are no known adverse interactions between them. Both address oxidative stress through different pathways, and the combination provides broader antioxidant coverage.

Should I take NAC during chemotherapy?

Discuss this with your oncologist before starting. The evidence for NAC in CIPN prevention is promising, but some chemotherapy protocols may be affected by antioxidant supplementation — particularly for chemotherapy regimens that work partly through generating ROS in cancer cells (where antioxidants could theoretically reduce treatment efficacy). The timing of NAC relative to infusions may also matter. This is a nuanced conversation best had with your oncology team, who can weigh the neuroprotection rationale against any treatment interference risk.

What does NAC smell like and does it matter?

NAC has a strong sulfurous odor (similar to rotten eggs) due to its thiol group. This is normal and does not indicate a bad product. Capsule formulations minimize odor exposure compared to powder forms. Some patients find the smell off-putting initially — knowing it’s expected helps. If you open capsules for any reason (e.g., for a child), the smell is pronounced.

Buy on Amazon — $15–$30 for a 60-day supply